Centralized federal litigation has been rejected for plaintiffs suing over several forms of birth control made by Qualitest Pharmaceuticals.

The U.S. Judicial Panel on Multidistrict Litigation has rejected the request of plaintiffs to centralize the litigation in the Northern District of Georgia. The plaintiffs allege that the birth control products were mispackaged so “the daily regimen for the birth control pills left them without adequate contraception and at risk for unwanted pregnancy,” according to the order from John G. Heyburn II, chairman of the judicial panel.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]